- AR
Company Introduction
As a leading manufacturing and trading enterprise specializing in pet pharmaceuticals and nutritional products, our company integrates research, development, production, and marketing to deliver high-quality solutions for pet health. Headquartered with a state-of-the-art manufacturing base in Changsha, Hunan, we combine advanced technology with industry expertise to meet global standards.
Founded by a team of over 10 PhDs and professor-level R&D experts, along with marketing executives, our company boasts deep industry resources and a vision for innovation. We have invested nearly 30 million RMB in establishing our production hub—Changsha Dongdian Pharmaceutical Co., Ltd.—which obtained the national veterinary GMP certification in July 2024. Spanning a modern facility, our base is equipped with over 100 sets of the latest automated equipment, 5 automated production lines, all with D-class or higher purification standards, and a traditional Chinese medicine extraction workshop. This infrastructure enables us to maintain high-efficiency production while ensuring strict quality control.
We specialize in 17 dosage forms, covering a comprehensive range of pet health solutions:
In total, we offer more than 80 products, encompassing medications and nutritional supplements for pet antiparasitics, dermatological treatments, and systems including digestive, respiratory, urinary, cardiovascular, nervous, and endocrine systems.
Our products cater to the full spectrum of pet health needs, addressing both therapeutic and preventive care. They are widely used in veterinary clinics and hospitals for treating common and specialized conditions, as well as for maintaining daily nutritional balance and overall wellness in pets.
Domestically, our products are distributed to over 8,500 pet hospitals and clinics across 30 provinces, municipalities, and autonomous regions in China. Internationally, we have expanded to markets in Southeast Asia, the United States, Canada, Europe, Russia, Australia, and beyond, delivering reliable pet health solutions to global customers.
Innovation lies at our core, with annual R&D investments accounting for 20% of our revenue. Currently, we have new veterinary drug projects under development with a contract value exceeding 40 million RMB. Our R&D team, composed of leading experts, focuses on creating safe, efficient, and innovative products, driving us to stay at the forefront of the pet pharmaceutical industry.
Committed to excellence, our production base adheres strictly to GMP standards, with automated processes and purified workshops ensuring consistent product quality. From raw material sourcing to final inspection, every step undergoes rigorous quality testing to meet both domestic and international regulatory requirements, guaranteeing reliability for our customers.
Driven by our mission—"To Keep Every Pet Healthy Worldwide"—we prioritize customer satisfaction. Our after-sales support includes technical guidance, product training, and prompt feedback handling, aiming to build long-term partnerships with clients. We are dedicated to providing comprehensive services that enhance the effectiveness and safety of our products.
Through continuous innovation and unwavering focus on quality, we strive to become a leading force in China's pet pharmaceutical industry, contributing to global pet health and welfare.
This introduction highlights our company's strengths in scale, product diversity, R&D prowess, and quality assurance, positioning us as a reliable partner for global pet health needs. For more details, please contact us via our Made-in-China store.
